poisar

Stocks · News reference

Evogene Announces Acute Graft-Versus-Host Disease as Target Indication for Internal AI-Driven Drug Discovery Program

Fiscal.ai

Evogene Ltd. has identified acute graft-versus-host disease (aGVHD) as the primary target indication for its internal AI-driven small-molecule drug discovery program.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading